年轻乳腺癌患者乳腺动态增强核磁特征和临床病理特征分析

Dynamic contrast-enhanced magnetic resonance imaging characteristics and clinicopathological features in young breast cancer patients

  • 摘要:
    背景 年轻乳腺癌具有肿瘤侵袭性强、预后差的特点,但其在乳腺动态增强核磁共振成像(dynamic contrast enhanced magnetic resonance imaging,DCE-MRI)上是否有特征性表现研究较少。
    目的 分析年轻女性乳腺癌患者乳腺MRI及临床病理特征。
    方法 回顾性分析2019年1月至2020年12月解放军总医院第一医学中心普通外科医学部收治的浸润性乳腺癌女性患者333例,根据年龄分为年轻乳腺癌组(25 ~ 40岁)和非年轻乳腺癌组(41 ~ 81岁)。分析两组术前乳腺DCE-MRI影像和临床病理特征。
    结果 共纳入333例患者,年轻乳腺癌组63例,非年轻乳腺癌组270例。年轻乳腺癌组和非年轻乳腺癌组相比较,发病部位、BMI、月经状态及高血压病史方面差异具有统计学意义(P<0.05)。DCE-MRI显示,与非年轻乳腺癌组相比,年轻乳腺癌组非肿块样强化比例更高(P=0.030),Ki-67表达水平和高表达率更高(均P<0.05)。与年轻乳腺癌肿块样强化亚组相比,年轻乳腺癌非肿块样强化亚组 ER表达水平更低(P=0.044)、PR高表达率更低(P=0.047)、保乳率更低(P=0.011)。
    结论 年轻乳腺癌患者具有独特的临床病理特征,乳腺MRI更多表现为NME,其可能与年轻乳腺癌患者更具侵袭性的病理类型及较差预后具有相关性。

     

    Abstract:
    Background The clinicopathological characteristics of young breast cancer patients are characterized by strong aggressiveness and poor prognosis. However, there are few studies on the dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) features of young breast cancer.
    Objective To investigate the MRI characteristics and clinicopathological features of young female breast cancer patients.
    Methods A retrospective analysis was conducted on female patients with invasive breast cancer treated in the Department of General Surgery of the First Medical Center of Chinese PLA General Hospital from January 2019 to December 2020. The patients were divided into young breast cancer group (25-40 years old) and non-young breast cancer group (41-81 years old). The preoperative breast DCE-MRI images and clinical pathological features were analyzed for both groups.
    Results Of the 333 cases, there were 63 cases in the young breast cancer group and 270 cases in the non-young breast cancer group. The young breast cancer group exhibited significant differences in several demographic and clinical variables compared to the non-young breast cancer group, including age, disease site, body mass index (BMI), menstrual status, and a history of hypertension (P<0.05). Notably, the young breast cancer group displayed a higher incidence of non-mass enhancement (NME) on DCE-MRI (P=0.030), along with elevated levels of Ki-67 expression and a higher expression rate (both P<0.05) when compared to the non-young breast cancer group. Furthermore, when compared to the young breast cancer mass enhancement subgroup, the young breast cancer non-mass enhancement subgroup had significantly lower expression levels of estrogen receptor (ER) (P=0.044), a lower high expression rate of progesterone receptor (PR) (P=0.047), and a lower rate of breast conserving surgery (P=0.011).
    Conclusion Young breast cancer patients exhibit unique clinical pathological features, with NME more commonly showing in breast MRI, which may be related to more invasive pathological types and poorer prognosis.

     

/

返回文章
返回